Becton, Dickinson and Company (BDX)
NYSE: BDX · Real-Time Price · USD
175.33
-3.52 (-1.97%)
At close: Jul 21, 2025, 4:00 PM
175.60
+0.27 (0.15%)
After-hours: Jul 21, 2025, 7:31 PM EDT

Company Description

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.

The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation systems, and medication inventory optimization and tracking systems; hemodynamic monitoring systems; and prefillable drug delivery systems.

The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers.

The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products.

The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Becton, Dickinson and Company
Becton, Dickinson and Company logo
CountryUnited States
Founded1897
IPO DateApr 23, 1962
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees73,000
CEOThomas Polen

Contact Details

Address:
1 Becton Drive
Franklin Lakes, New Jersey 07417-1880
United States
Phone201 847 6800
Websitebd.com

Stock Details

Ticker SymbolBDX
ExchangeNYSE
Stock TypeCommon Stock
Fiscal YearOctober - September
Reporting CurrencyUSD
CIK Code0000010795
CUSIP Number075887109
ISIN NumberUS0758871091
Employer ID22-0760120
SIC Code3841

Key Executives

NamePosition
Thomas E. Polen Jr.President, Chief Executive Officer and Chairman
Christopher J. DelOrefice CPAExecutive Vice President and Chief Financial Officer
Shana Carol NealExecutive Vice President and Chief People Officer
Michael GarrisonExecutive Vice President and President of Medical segment
Richard ByrdExecutive Vice President and President of Interventional Segment
Pamela L. SpiknerSenior Vice President, Chief Accounting Officer and Controller
Elizabeth McCombsExecutive Vice President and Chief Technology Officer
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.Senior Vice President and Chief Scientific Officer
Denise Russell FlemingExecutive Vice President of Technology and Global Services and Chief Information Officer
Greg RodetisSenior Vice President, Treasurer and Head of Investor Relations

Latest SEC Filings

DateTypeTitle
Jul 18, 2025144Filing
Jul 14, 2025425Filing
Jul 14, 2025425Filing
Jul 14, 2025425Filing
Jul 14, 2025425Filing
Jul 14, 2025425Filing
Jul 14, 20258-KCurrent Report
Jul 14, 2025425Filing
Jul 14, 20258-KCurrent Report
Jul 7, 2025SCHEDULE 13G/AFiling